scholarly journals Medication Underuse During Long-Term Follow-Up in Patients With Peripheral Arterial Disease

2009 ◽  
Vol 2 (4) ◽  
pp. 338-343 ◽  
Author(s):  
Sanne E. Hoeks ◽  
Wilma J.M. Scholte op Reimer ◽  
Yvette R.B.M. van Gestel ◽  
Olaf Schouten ◽  
Mattie J. Lenzen ◽  
...  
Keyword(s):  
Peripheral Arterial Disease ◽  
Arterial Disease ◽  
Long Term Follow Up ◽  
Peripheral Arterial

scholarly journals Priporočila za odkrivanje in zdravljenje periferne arterijske bolezni

2017 ◽  
Vol 86 (3-4) ◽  
Author(s):  
Aleš Blinc ◽  
Matija Kozak ◽  
Mišo Šabovič ◽  
Vinko Boc ◽  
Pavel Poredoš ◽  
...  
Keyword(s):  
Peripheral Arterial Disease ◽  
Arterial Disease ◽  
Therapeutic Procedures ◽  
Long Term Follow Up ◽  
Peripheral Arterial

In the article, recommendations for the diagnostics in suspected peripheral arterial disease are presented together with  therapeutic procedures and long- term follow up of the affected patients.

scholarly journals Characteristics and Long-Term Follow-Up of Participants with Peripheral Arterial Disease During ALLHAT

2014 ◽  
Vol 29 (11) ◽  
pp. 1475-1483 ◽  
Author(s):  
Linda B. Piller ◽  
◽  
Lara M. Simpson ◽  
Sarah Baraniuk ◽  
Gabriel B. Habib ◽  
...  
Keyword(s):  
Peripheral Arterial Disease ◽  
Arterial Disease ◽  
Long Term Follow Up ◽  
Peripheral Arterial

scholarly journals Long-term outcomes of peripheral arterial disease patients with significant coronary artery disease undergoing percutaneous coronary intervention

PLoS ONE ◽  
2021 ◽  
Vol 16 (5) ◽  
pp. e0251542
Author(s):  
Byoung Geol Choi ◽  
Ji-Yeon Hong ◽  
Seung-Woon Rha ◽  
Cheol Ung Choi ◽  
Michael S. Lee
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Peripheral Arterial Disease ◽  
Significant Coronary Artery Disease ◽  
Arterial Disease ◽  
Term Survival ◽  
Artery Disease ◽  
Peripheral Arterial

Background Patients with peripheral arterial disease (PAD) have known to a high risk of cardiac mortality. However, the effectiveness of the routine evaluation of coronary arteries such as routine coronary angiography (CAG) in PAD patients receiving percutaneous transluminal angioplasty (PTA) is unclear. Methods A total of 765 consecutive PAD patients underwent successful PTA and 674 patients (88.1%) underwent routine CAG. Coronary artery disease (CAD) was defined as angiographic stenosis ≥70%. Patients were divided into three groups; 1) routine CAG and a presence of CAD (n = 413 patients), 2) routine CAG and no CAD group (n = 261 patients), and 3) no CAG group (n = 91 patients). To adjust for any potential confounders that could cause bias, multivariable Cox-proportional hazards regression and propensity score matching (PSM) analysis was performed. Clinical outcomes were evaluated by Kaplan-Meier curved analysis at 5-year follow-up. Results In this study, the 5-year survival rate of patients with PAD who underwent PTA was 88.5%. Survival rates were similar among the CAD group, the no CAD group, and the no CAG group, respectively (87.7% vs. 90.4% vs. 86.8% P = 0.241). After PSM analysis between the CAD group and the no CAD group, during the 5-year clinical follow-up, there were no differences in the incidence of death, myocardial infarction, strokes, peripheral revascularization, or target extremity surgeries between the two groups except for repeat PCI, which was higher in the CAD group than the non-CAD group (9.3% vs. 0.8%, P<0.001). Conclusion PAD patients with CAD were expected to have very poor long-term survival, but they are shown no different long-term prognosis such as mortality compared to PAD patients without CAD. These PAD patients with CAD had received PCI and/or optimal medication treatment after the CAG. Therefore a strategy of routine CAG and subsequent PCI, if required, appears to be a reasonable strategy for mortality risk reduction of PAD patients. Our results highlight the importance for evaluation for CAD in patients with PAD.

scholarly journals Vasoactive Biomarkers Associated With Long-Term Incidence of Symptomatic Peripheral Arterial Disease and Mortality

Angiology ◽  
2021 ◽  
pp. 000331972098773
Author(s):  
Ardwan Dakhel ◽  
Gunnar Engström ◽  
Olle Melander ◽  
Stefan Acosta ◽  
Shahab Fatemi ◽  
...  
Keyword(s):  
Cohort Study ◽  
Peripheral Arterial Disease ◽  
Proportional Hazards ◽  
Arterial Disease ◽  
Cox Proportional Hazards ◽  
Cox Proportional Hazards Regression ◽  
Proportional Hazards Regression ◽  
Peripheral Arterial

We evaluated if plasma biomarkers can predict incident peripheral arterial disease (PAD) and mortality in a longitudinal cohort study. Men (n = 3618) and women (n = 1542) were included in the Malmö Preventive Project and underwent analysis of: C-terminal endothelin-1 (CT-proET-1), N-Terminal prosomatostatin (NT-proSST), midregional proatrial natriuretic peptide (MR-proANP), procalcitonin (PCT), and copeptin. Participants were followed up for incident PAD and mortality until December 31, 2016. Median follow-up was 11.2 years (interquartile range 9.4-12.2). Cumulative incidence of PAD was 4.3% (221/5160), 4.5% in men (164/3618) and 3.7% in women (57/1542; P = .174). In an adjusted Cox proportional hazards regression model, higher CT-proET-1 (hazard ratio [HR] 1.8; 95% confidence interval [CI] 1.4-2.3), NT-proSST (HR 1.5; 95% CI 1.2-2.0), and MR-proANP (HR 1.7; 95% CI 1.3-2.3) were independently associated with incident PAD, and higher CT-proET-1 (HR 1.3; 95% CI 1.2-1.5), NT-proSST (HR 1.2; 95% CI 1.1-1.3), MR-proANP (HR 1.4; 95% CI 1.3-1.6), PCT (HR 1.1; 95% CI 1.0-1.2), and copeptin (HR 1.2; 95% CI 1.1-1.4) were independently associated with mortality. Increased levels of CT-proET-1, NT-proSST, and MR-proANP were independently associated with incident PAD, whereas all the vasoactive biomarkers were independently associated with mortality during follow-up.

Structured surveillance of patients with peripheral arterial occlusive disease after peripheral vascular interventions

VASA ◽  
2009 ◽  
Vol 38 (4) ◽  
pp. 302-315 ◽  
Author(s):  
Weiss ◽  
Bergert
Keyword(s):  
Peripheral Arterial Disease ◽  
Integrated Approach ◽  
Arterial Disease ◽  
Evidence Based ◽  
Peripheral Vascular ◽  
Vascular Intervention ◽  
Peripheral Arterial

Longterm follow-up and surveillance after either an endovascular or an open surgical vascular intervention is an essential part of the angiologist’s or vascular surgeon’s care for patients with peripheral arterial disease. This includes diagnosis and treatment of cardiovascular risk factors, selection and monitoring of antiplatelet and/or anticoagulant therapy after revascularization, and surveillance of the results of the vascular intervention. This integrated approach to patients’ care will improve patients’ prognosis quoad vitam and quoad extremitatem and their quality of life. We summarize the rationale and evidence-based practical approaches and guidelines for structured long term surveillance of patients with peripheral arterial disease after a vascular intervention.

Sign in / Sign up

Export Citation Format

Share Document